Monthly Prescribing Reference

FDA Approves Use of Optison in Pediatric Patients With Suboptimal Echocardiograms

Expanding the approval to pediatric patients is expected to improve the diagnostic accuracy of echocardiograms. The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A ...
Business Wire

GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent

The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients Optison is the only polyethylene glycol (PEG)-free ultrasound ...
Business Wire

GE Healthcare Medical Diagnostics Relaunches Optison™ Contrast Agent in Europe | Business Wire

OPTISON should be used in these categories of patients only after careful consideration, and monitored closely during and after administration. Other routes of administration not specified in section ...
Nasdaq

GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use

GE HealthCare Technologies Inc. GEHC recently announced FDA approval for Optison, its polyethylene glycol (PEG)-free ultrasound enhancing agent, for use in pediatric patients. This milestone expands ...
Nasdaq

GE HealthCare Announces FDA Approval For Pediatric Use Of Optison Ultrasound Enhancing Agent

(RTTNews) - GE HealthCare (GEHC) announced Tuesday the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company's Optison (Perflutren Protein-Type A Microspheres ...